Tennessee HB0428 mandates coverage for continuous glucose monitors for certain diabetes patients.
Tennessee HB0428 amends the state code to require coverage for continuous glucose monitors (CGM) for patients enrolled in TennCare. Coverage is mandatory for those diagnosed with Type 1 diabetes, gestational diabetes, problematic hypoglycemia, or requiring insulin use. For Type 2 diabetes patients, coverage is required if they meet specific criteria, such as a hemoglobin A1C level of 7% or higher. CGM coverage is contingent on a prescription from an endocrinologist or healthcare practitioner experienced in diabetes management. The act takes effect January 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.